|
Propofol vs. Ketamine:
Data Sheet, Data Collection Tips, Study Flow, FAQs
|
|
Overview:
A study designed to determine the
efficacy and safety of propofol vs. ketamine in moderate procedural
sedations |
|
Study Endpoints:
1. Respiratory depression as assessed by ETCO2 2. Mental status as
assessed by OAAS, and patient report. |
|
Eligible Patients:
Adult (≥18 y.o.) patients undergoing a procedural sedation for any
reason. |
|
Study Design:
Prospective, randomized clinical trial.
|
|
Anticipated
Benefits: ETCO2 monitoring mandated by the study may improve safety
of procedure.
|
|
Potential Risks:
The usual risks associated with procedural sedation.
|
|
Research Associate’s
Role: The RA is responsible for identifying, enrolling, and
collecting data from eligible patients for this study. The RA is in
charge of setting up and putting away the End-Tidal CO2
monitor used to obtain data during the procedure. After the study, the
RA conducts interviews of the physician and the patient. Note - BIS
Monitor will not be used for this study!!
|
|
Physician’s Role:
The RA will ask you to notify them of any conscious sedations being
performed so that they may enter the patient into the study. You will
be asked to perform the sedation using either propofol or ketamine. Once
the procedure is over, you will be asked to complete a short
questionnaire about the success of the procedure and the time it took
for the patient to return to baseline mental status.
|
|
Location of Study
Packets: Team Center B
|
